Peter Chen Selected Research

NK Cell Lectin-Like Receptor Subfamily B

1/2015

Modulation of Clr Ligand Expression and NKR-P1 Receptor Function during Murine Cytomegalovirus Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Chen Research Topics

Disease

21	Neoplasms (Cancer) 06/2022 - 08/2002
16	COVID-19 05/2022 - 01/2020
14	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2002
12	Lung Injury 01/2020 - 09/2005
9	Infections 01/2022 - 01/2015
8	Inflammation (Inflammations) 01/2021 - 09/2005
8	Fibrosis (Cirrhosis) 01/2021 - 09/2005
7	Pneumonia (Pneumonitis) 12/2020 - 09/2005
6	Wounds and Injuries (Trauma) 01/2021 - 05/2008
4	Burns 01/2022 - 06/2014
4	Acute Lung Injury 12/2018 - 09/2005
4	Head and Neck Neoplasms (Head and Neck Cancer) 09/2018 - 01/2012
3	Atypical Hemolytic Uremic Syndrome 05/2022 - 01/2021
3	Sepsis (Septicemia) 01/2022 - 01/2018
3	Disease Progression 10/2021 - 07/2011
3	Anterior Cruciate Ligament Injuries 08/2020 - 06/2010
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2019 - 10/2013
3	Human Influenza (Influenza) 12/2018 - 01/2016
3	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2017 - 12/2005
3	Necrosis 08/2017 - 09/2014
3	Hematoma 11/2016 - 03/2005
3	Erythema 11/2016 - 11/2007
3	Margins of Excision 11/2016 - 08/2003
3	Heart Failure 12/2015 - 05/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015 - 01/2012
2	Pain (Aches) 05/2022 - 02/2022
2	Fatigue 05/2022 - 05/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2011
2	AIDS-Related Complex (ARC) 01/2022 - 10/2020
2	Insulin Resistance 01/2021 - 06/2014
2	Idiopathic Pulmonary Fibrosis 12/2016 - 04/2015
2	Hemorrhage 07/2012 - 09/2005
2	Prostatic Neoplasms (Prostate Cancer) 07/2012 - 02/2005
2	Endometrial Neoplasms (Endometrial Cancer) 06/2005 - 08/2002
1	Headache (Headaches) 05/2022
1	Dyspnea (Shortness of Breath) 05/2022
1	Chills 05/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2022
1	Healthcare-Associated Pneumonia 01/2022
1	Hypertension (High Blood Pressure) 01/2022

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 12/2018 - 09/2005
8	Matrix Metalloproteinases (MMPs)IBA 12/2018 - 04/2006
7	bamlanivimabIBA 05/2022 - 01/2021
5	etesevimabIBA 05/2022 - 01/2021
5	bamlanivimab and etesevimab drug combinationIBA 05/2022 - 01/2021
5	Estrogen ReceptorsIBA 08/2017 - 08/2003
4	Syndecan-1 (Syndecan 1)IBA 01/2019 - 08/2009
4	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2016
4	Tissue Inhibitor of Metalloproteinase-1IBA 12/2018 - 09/2005
4	Phenobarbital (Luminal)FDA Link 07/2017 - 04/2006
4	Bleomycin (Blenoxane)FDA LinkGeneric 12/2016 - 09/2005
3	ravulizumabIBA 05/2022 - 01/2021
3	eculizumab FDA Link 05/2022 - 01/2021
3	Neutralizing AntibodiesIBA 01/2022 - 01/2021
3	InflammasomesIBA 01/2022 - 06/2014
3	Biological ProductsIBA 01/2021 - 05/2015
3	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2020
3	Matrix Metalloproteinase 7 (Matrilysin)IBA 03/2013 - 05/2008
3	Tamoxifen FDA LinkGeneric 03/2011 - 08/2003
2	VaccinesIBA 02/2022 - 10/2021
2	Pharmaceutical PreparationsIBA 02/2022 - 09/2002
2	Messenger RNA (mRNA)IBA 01/2022 - 08/2002
2	Protons (Proton)IBA 01/2022 - 10/2020
2	Monoclonal AntibodiesIBA 10/2021 - 01/2021
2	Small Cytoplasmic RNAIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2015
2	Oxygen (Dioxygen)IBA 12/2020 - 04/2016
2	Cysteine (L-Cysteine)FDA Link 01/2020 - 04/2015
2	Leukotriene E4IBA 12/2019 - 04/2016
2	Transcription Factors (Transcription Factor)IBA 11/2019 - 03/2011
2	NucleotidesIBA 01/2019 - 06/2014
2	Leucine (L-Leucine)FDA Link 01/2019 - 06/2014
2	Interleukin-6 (Interleukin 6)IBA 04/2017 - 01/2017
2	CytokinesIBA 01/2017 - 06/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2016 - 10/2016
2	ApolipoproteinsIBA 04/2016 - 02/2006
2	LigandsIBA 01/2015 - 09/2010
2	Cetuximab (Erbitux)FDA Link 04/2014 - 01/2012
2	Peptide Hydrolases (Proteases)FDA Link 12/2009 - 04/2006
1	Complement Inactivating AgentsIBA 05/2022
1	COVID-19 VaccinesIBA 02/2022
1	BNT162 VaccineIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022

Therapy/Procedure

19	Therapeutics 02/2022 - 08/2003
18	Radiotherapy 06/2022 - 07/2002
8	Brachytherapy 01/2018 - 01/2002
7	Segmental Mastectomy (Lumpectomy) 10/2018 - 08/2003
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 04/2008
3	Proton Therapy 01/2022 - 09/2018
3	Intravenous Infusions 10/2021 - 12/2020
3	Spinal Cord Stimulation 12/2015 - 05/2012
3	Drug Therapy (Chemotherapy) 04/2014 - 07/2011
2	Critical Care (Surgical Intensive Care) 01/2020 - 09/2002
2	Lung Transplantation 12/2016 - 04/2006
2	Catheters 07/2012 - 09/2007
2	Aftercare (After-Treatment) 11/2007 - 12/2005
2	Mastectomy (Mammectomy) 12/2005 - 08/2003
1	Dental Care 02/2022
1	Duration of Therapy 01/2022
1	Operative Time 01/2022